Barrington lowered the firm’s price target on Option Care Health (OPCH) to $32 from $40 and keeps an Outperform rating on the shares following the Q3 report. The firm cites the company’s commentary related to the Stelara issue for the target cut.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OPCH: